Field output correction factors using a fully characterized plastic scintillation detector (HYPERSCINT RP-200)

As small fields become increasingly important in radiation therapy, accurate dosimetry is essential for ensuring precise dose calculation and treatment optimization. Despite the availability of small volume detectors, small field dosimetry remains challenging. The new plastic scintillation detector (PSD) from the HYPERCINT RP-200 platform from Medscint offers a promising solution with minimal correction requirements for small field measurements.

This study focused on characterizing the field output correction factors of the PSD across a wide range of field sizes and demonstrating its potential for determining correction factors for other small field detectors. Monte Carlo simulations and experimental comparisons were used to assess the system’s performance. The PSD exhibited near-unity correction factors (1.002 to 0.999) across field sizes between 0.6×0.6 cm² and 30×30 cm², with an impressive total uncertainty of 0.5%.

The PSD is shown to be a highly accurate and reliable detector for small field dosimetry, and it can also be used to determine correction factors for other dosimeters with great precision.

PREPRINT
Luc Gingras (1,2), Yunuen Cervantes (1,2,3), Frederic Beaulieu (1,2), Magali Besnier (1,2), Benjamin Coté (4), Simon Lambert-Girard (4), Danahé LeBlanc (4), Yoan LeChasseur (4), François Therriault-Proulx (4), Luc Beaulieu (1,2,3), Louis Archambault (1,2,3) | 1. CHU de Québec–Université Laval, Québec – Canada, 2. Centre de recherche du CHU de Québec, Québec – Canada, 3. Université Laval, Québec – Canada, 4. Medscint, Québec – Canada

Development and first implementation of a novel multi-modality cardiac motion and dosimetry phantom for radiotherapy applications

Magnetic resonance guided radiation therapy (MRgRT) for real-time gating around the heart for treating ventricular tachycardia (VT) are rapidly advancing. A novel, multi-modality modular heart phantom was developed and utilized in gated radiotherapy experiments on a 0.35 T MR-linac. This phantom can simulate cardiac, cardio-respiratory, and respiratory motions, and perform dosimetric evaluations using ionization chamber and plastic scintillation detectors (PSD from MEDSCINT) configurations.

Due to their small sensitive volumes, time-resolved PSDs are effective for low-amplitude/high-frequency movements and multi-point data acquisition, enhancing dosimetric capabilities. This advancement in VT planning and delivery illustrates the phantom’s potential to meet the growing demands of cardiac applications in radiotherapy.

MEDICAL PHYSICS
Kenneth W. Gregg (1,2), Chase Ruff (1,2), Grant Koenig (3), Kalin I. Penev (3), Andrew Shepard (1), Grace Kreissler (4), Margo Amatuzio (4), Cameron Owens (4), Prashant Nagpal (5), Carri K. Glide-Hurst (1,2) | 1. Department of Human Oncology, University of Wisconsin–Madison, Madison, Wisconsin, USA, 2. Department of Medical Physics, University of Wisconsin–Madison, Madison, Wisconsin, USA, 3. Modus Medical Devices, Inc. (IBA QUASAR),London, Ontario, Canada, 4. Department of Biomedical Engineering, University of Wisconsin–Madison, Madison, Wisconsin, USA, 5. Department of Radiology, University of Wisconsin–Madison, Madison, Wisconsin, USA

Characterization of a multi-point scintillation dosimetry research platform for a low-field MR-Linac

Plastic scintillation detectors (PSDs) are attractive for enhancing MRI-guided radiation therapy (MRgRT). A study evaluating the HYPERSCINT RP-200, a multi-probe PSD system, demonstrated excellent repeatability and minimal deviation in performance metrics such as detector response and percent depth dose (PDD). PSDs maintained consistent linearity across a broad range of monitor units and showcased high accuracy in gating experiments (ex. gating experiments where 400 cGy were delivered to isocenter : < 0.8 cGy variation for central axis measures and < 0.7 cGy for the gradient sampled region). These results highlight PSDs' huge potential in improving the precision and reliability of MRgRT, especially in complex real-time applications.

MEDICAL PHYSICS
Jennie Crosby (1), Chase Ruff (1), Ken Gregg (1), Jonathan Turcotte (2), Carri Glide-Hurst (1) | 1. Department of Human Oncology, University of Wisconsin-Madison, Madison, Wisconsin, USA, 2. Medscint, Québec, Quebec, Canada

MLC tracking and dose accumulation validation on the MR-linac using a real-time deformable dosimeter

Online MRI on the MR-linac captures detailed anatomical movements, improving real-time radiotherapy adaptations. However, the lack of a suitable MRI-compatible phantom hinders workflow validation. This study introduces a deformable phantom with integrated real-time scintillation dosimeters, validating accuracy in MLC tracking and dose accumulation using the ELEKTA Unity MR-linac.

This study demonstrates the vast potential of this novel prototype deformable phantom with integrated PSDs for real-time dosimetry measurements on an MR-linac.

2024 ESTRO Annual Congress
Madelon van den Dobbelsteen (1), Pim T.S. Borman (1), Laurie J.M. de Vries (1), Sara L. Hackett (1), Kalin Penev (1), Rocco Flores (2), Stephanie Smith (2), Yoan LeChasseur (3), Simon Lambert-Girard (3), Benjamin Côté (3) , Peter L. Woodhead (1)(4), Lando S. Bosma (1), Cornel Zachiu (1), Bas W. Raaymakers (1), Martin F. Fast (1) | 1 University Medical Center Utrecht, Radiotherapy, Utrecht, Netherlands., 2 IBA QUASAR, Modus Medical Devices Inc. London ON, Canada. , 3 Medscint, -, Quebec City, Canada. , 4 Elekta AB, -, Stockholm, Sweden.

Experimental dosimetric verification of the intra-fraction drift correction on the 1.5 T MR-linac

MRI-guided online adaptive treatments can improve tumor targeting by adjusting treatment plans in real-time based on cine MR-scans. And to correct the intra-fraction motion, Elekta AB introduced the intra-fraction drift correction (IDC) functionality for the 1.5 T Unity MR-linac.

The IDC is a valuable functionality for fast intra-fraction adaptations and this research experimentally verifies the geometric and dosimetric accuracy of the IDC process using film, scintillation, and diode dosimetry.

ESTRO 2024 Annual Congress
Madelon van den Dobbelsteen, Sara L. Hackett, Stijn Oolbekkink, Bram van Asselen, Prescilla Uijtewaal, Martin F. Fast, Bas W. Raaymakers | University Medical Center Utrecht, Radiotherapy, Utrecht, Netherlands

Evaluation of the HYPERSCINT scintillation dosimetry platform for small-field characterization of a Leksell GAMMA KNIFE

The performance of the HYPERSCINT RP-200 with the 0.5mm x 0.5mm detector was evaluated for the characterization of small radiation fields administered using a Leksell Gamma Knife Perfexion radiosurgery device. Overall, our results show that the detector response was in close agreement with Gamma Knife Monte Carlo reference data and film measurements. Based on the obtained results, the plastic scintillation detector shows the potential for rapid validation of output factors and validation of film measurements as well its use in challenging small-field situations encountered with the Gamma Knife.

ISRS 2024 – New York
Mathieu GUILLOT (1), Patrick DELAGE (1), Vincent HUBERT-TREMBLAY (1), Francois THERRIAULT-PROULX (2), Danahé LEBLANC (2) | CHUS – Sherbrooke, Canada, Medscint – Québec, Canada

Development of End-to-End Preclinical Treatment Verification Procedures, Traceable to NPL Air Kerma Primary Standard

Dosimetry audits are an important tool to improve quality of reported results and to support standardization of preclinical radiation research. This work presents how the combination of passive and active detectors, such as the real-time HYPERSCINT scintillation dosimetry solution, with anatomically correct mouse phantoms are adequate for the development of End-to-End dosimetry audits for the independent verification of preclinical radiation treatments.

The traceability of the detectors’ calibration to primary standards strengthens the dosimetry chain in the validation of preclinical plans, and it is consistent with the current practice for dose traceability of clinical radiotherapy treatments. Their implementation at national and regional levels could lead to databases of anonymised records, which will positively impact the dissemination of best practices and sharing of validated results.

6th Conference on small animal precision image-guided radiotherapy
Ileana Silvestre Patallo (1), Rebecca Carter (2)(3), Andrew Nisbet (2), Anna Subiel (1), Giuseppe Schettino (1) | 1. National Physical Laboratory, UK, 2. University College London, UK, 3. Cancer Institut, UK

Characterization of a novel time-resolved, real-time scintillation dosimetry system (HYPERSCINT RP-FLASH) for ultra-high dose rate radiation therapy applications

This study evaluates a novel scintillation dosimetry solution developed by Medscint for ultra-high dose rate (UHDR) radiotherapy, the HYPERSCINT RP-FLASH. The system was tested on an UHDR electron beamline, demonstrating dose linearity and independence from dose rate (1.8–1341 Gy/s) and dose per pulse (0.005–7.68 Gy) within ±3% tolerance. The system accurately measured doses per pulse up to 120 Hz.

With daily calibrations and specific correction factors, the system provides real-time, millisecond-resolved dosimetric measurements for pulsed conventional and UHDR beams, showing promise for applications in FLASH-RT.

PREPRINT
Alexander Baikalov (1,2,3), Daline Tho (1), Kevin Liu (1,4), Stefan Bartzsch (2,3), Sam Beddar (1,4), Emil Schüler (1,4) | 1. University of Texas MD Anderson Cancer Center, Houston, TX – USA, 2. Technical University of Munich – Germany, 3. German Research Center for Environmental Health, Neuherberg – Germany, 4. The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX – USA

Characterization of a 0.8 mm³ Medscint Plastic Scintillator Detector System for Small Field Dosimetry

The scintillator-based dosimetry system HYPERSCINT RP-200, coupled with a 0.8 mm³ plastic scintillator detector, demonstrated excellent dosimetric properties for small field radiation therapy, including good repeatability, dose linearity, and accuracy down to field sizes as small as 0.5 × 0.5 cm².

Physics in Medicine & Biology
Elena Timakova (1,2), Magdalena Bazalova-Carter (1) , Sergei Zavgorodni (2) | 1. University of Victoria, British Columbia, Canada, 2. BC Cancer Agency, Vancouver Island Centre, British Columbia, Canada